Because the mechanisms of Helicobacter pylori-induced gastric injury are incompletely understood, we examined the hypothesis that H. pylori induces matrix metalloproteinase-1 (MMP-1) secretion, with potential to disrupt gastric stroma. We further tested the role of CagA, an H. pylori virulence factor, in MMP-1 secretion. Co-incubation of AGS cells with Tx30a, an H. pylori strain lacking the cagA virulence gene, stimulated MMP-1 secretion, confirming cagA-independent secretion. Coincubation with strain 147C (cagA+) resulted in CagA translocation into AGS cells and increased MMP-1 secretion relative to Tx30a. Transfection of cells with the recombinant 147C c a g A gene also induced MMP-1 secretion, indicating that CagA can independently stimulate MMP-1 secretion. Co-incubation with strain 147A, containing a cagA gene that lacks an EPIYA tyrosine phosphorylation motif, as well as transfection with 147A cagA, yielded MMP-1 secretion intermediate between no treatment and 147C, i n d i c a t i n g t h a t C a g A t y r o s i n e phosphorylation regulates cellular signaling in this model system. H. pylori induced activation of the MAP kinase Erk, with CagA-independent (early) and dependent (later) components. Mek inhibitors UO126 and PD98059 inhibited both CagAindependent and dependent MMP-1 secretion, whereas p38 inhibition enhanced MMP-1 secretion and Erk activation, suggesting p38 negative regulation of MMP-1 and Erk. These data indicate H. pylori effects on host epithelial MMP-1 expression via Erk, with p38 playing an important regulatory role.
Helicobacter pylori, highly prevalent in developed nations, and ubiquitous in developing countries (1) , is an important risk factor for peptic ulcer disease, gastric adenocarcinoma, and gastric lymphoma (2, 3) . However, the mechanisms through which H. pylori induces gastric damage are not well elucidated. H . pylori, an extracellular bacterium that attaches to gastric epithelial cells via adhesins (4) , has evolved to survive within the gastric mucus layer (5) . H. pylori strains may possess the cag pathogenicity island, (cagI) 2 (6) , a 35-40 Kb region that contains 25 to 30 open reading frames. Several cagI genes encode a type IV secretion system (7) , an assembly that permits introduction of CagA, a cagI-encoded protein of approximately 128 kDa (8, 9) , into the host gastric epithelial cell. Most CagA isotypes include one or more type C EPIYA motifs that are subject to tyrosine phosphorylation by host cell c-Src/Lyn kinases (10) . Phosphorylated CagA interacts with, and activates, the host cell SHP-2 phosphatase, which serves as an important CagA effector (11, 12) . The presence of CagA within epithelial cells induces morphologic changes (scattered, or hummingbird phenotype), including formation of extensive host cell filopodia (13) . Other cagA and/or cagI-related effects include increased host cell apoptosis (14) , nuclear factor-kB activation (15) , and secretion of proinflammatory chemokines such as interleukin-6 and 8 (16, 17) . Compared to c a g A-strains, cagA+ strains are associated with increased risk of peptic ulcer disease and carcinogenesis (18, 19) .
When secreted and activated, matrix metalloproteinases (MMPs) digest extracellular connective tissue (20) . In rheumatoid arthritis, MMP secretion by synovial fibroblasts in response to cytokines contributes to cartilage and bone destruction (21, 22) . Similarly, proinflammatory cytokines, such as interleukin-1b and tumor necrosis factor-a, stimulate gastric epithelial cells to synthesize and secrete MMPs (23) . Moreover, exposure of gastric epithelial cells to H. pylori also results in MMP secretion, including MMP-3,7 and 9 (24) (25) (26) . Upregulated MMP expression has been associated with gastric ulceration and neoplasia in humans and in animal models (25) (26) (27) (28) (29) (30) , suggesting that MMPs participate in gastric tissue erosion and/or tumor invasion. However, the role of CagA in H. pylori-induced MMP secretion has not been fully elucidated.
The mitogen-activated protein kinases (MAPKs) are serine/threonine kinases including Erk, Jnk, and p38 subfamilies (31, 32) . Whereas Jnk and p38 regulate inflammation (33, 34) , Erk is mitogen-responsive, and regulates cell growth and differentiation (31) . However, Erk also can regulate inflammatory responses, including neutrophil adhesion and superoxide generation (35) . In synovial fibroblasts, Erk activation mediates cytokine-and growth factor-stimulated MMP-1 secretion, enhancing tissue destruction in inflammatory arthritis (36) . Although H . pylori stimulates Erk activation in gastric epithelial cells (37) (38) (39) (40) (41) , the kinetics of Erk activation, as well as the role of CagA in this process, are not fully understood. H. pylori activation of gastric epithelial cell Erk may regulate both chemokine secretion and nuclear factor-kB activation (42) , contributing to proinflammatory responses. In response to H. pylori and gastrin, secretion of MMP-7 and MMP-9, respectively, may be regulated by Erk (26, 43) . In response to cytokines, Erk mediates, and p38 inhibits, gastric cell MMP-1 secretion (23) . Since the primary connective tissue components of gastric stroma are proteins susceptible to MMP-1 degradation (29, 44, 45) , MMP-1 secretion may be particularly relevant to the pathogenesis of gastric damage.
In the present studies, we examined the role of H pylori in gastric cell MMP-1 secretion, and the regulation of this process by MAP kinases. We report that H. pylori stimulates gastric epithelial cell MMP-1 secretion via both CagA-dependent and independent mechanisms. Both processes are mediated by Erk, and inhibited by p38. CagA, and particularly the CagA tyrosine phosphorylation site (EPIYA motif), is required for optimal Erk activation and MMP-1 secretion. (47) , variation in cagA genotypes within the total population may regulate the signal intensity leading to MMP-1 secretion.
EXPERIMENTAL PROCEDURES
Materials -Unless otherwise stated, all materials were from Sigma. Anti-phosphoErk, Erk 1 and Erk 2 antisera, and horseradish peroxidaseconjugated anti-rabbit antiserum were from Santa Cruz Biotechnology. Anti-MMP-1 and MMP-13 antisera were from Chemicon. 10% tris-glycine/polyacrylamide gels were from Novex/Invitrogen. UO126, PD98059 and SB203580 were from Biomol. SB202190 was from Calbiochem. Centricon™ centrifugal filter devices were from Millipore, and RPMI medium, Fetal Bovine Serum (FBS) and 2.5% trypsin/EDTA from BioWhittaker. Penicillin G sodium (10,000 u/ml)/Streptomycin sulfate (10,000 µg/ml) in 0.85% NaCl was from Gibco. The ECL chemiluminescence kit was from Amersham. Bacterial strains -To determine the effects of H. pylori on AGS cell MMP-1 secretion, we employed three H. pylori strains. Strain Tx30a (48) , also reported as strain 88-22 (47) , lacks the Cag pathogenicity island, and is of low pathogenicity. In contrast, strains 147A and 147C are clonally-derived cagI+ strains that were isolated from different gastric regions of the same patient, and are nearly identical except for sequence differences in the 3' end of cagA. 147C possesses a C-type EPIYA motif that is absent in 147A. Since the C-type EPIYA tyrosine in 147C is the target for CagA phosphorylation by the host cell kinase Src, 147A is not susceptible to phosphorylation (47) . Strain 7bqs, used to derive the 7bqs cagA construct, was obtained from a different host than 147A and 147C (47) . Cell culture and cell treatment -AGS cells (American Type Culture Collection Number CRL-1739)), a human cell line derived from a gastric epithelial tumor (49, 50) , were cultured in 6-well plates in RPMI medium containing 10% FBS and penicillin/streptomycin. Cells grown to near-confluence were serum-starved for 24 h (0% fetal bovine serum), followed by equilibration with fresh medium for 30-60 min prior to co-culture with H. pylori and/or other treatment. Unless otherwise specified, the following concentrations of reagents were used: UO126, SB203580, SB202190 each at 10 µM; PD98059 at 50 µM. AGS cell co-culture and transfection -Serumstarved AGS cells were co-cultured with H . pylori cells of strain Tx30a, 147A, or 147C, at a ratio of 100 bacterial cells/AGS cell.. The cultures were incubated for indicated times at 37°C, and supernatants collected, concentrated, and analyzed, as described (23) . Adherent cells were washed x3 with cold phosphate-buffered saline, lysed [20 mM Tris, pH 7.4, 1 mM EGTA, 2 mM sodium vanadate, 25 mM sodium fluoride, 0.5% (vol/vol) Triton X-100, 2 mM PMSF, 10 5 kallikrein units/ml aprotinin, and 10 µg/ml each of chymostatin, antipain, and pepstatin] for 20 min at 4°C, as described (36) , and lysates collected and used directly or frozen for further study.
AGS cells grown to approximately 50% confluence were transfected using the Superfect™ transfection system, according to the manufacturer's instructions (Qiagen, Valencia, CA). Typically, 15 µl Superfect™ was used/5µg DNA/well in 6-well plates. UO126, PD98059, SB203580 or SB202190 was added to cells at the time of transfection. After 2-3 h, the medium was replaced with serum-free medium (still containing the appropriate inhibitor), incubation continued, and supernatant and/or lysates analyzed for MMP-1, Erk, or CagA. Immunoblotting and Determination of Raf, Mek and Erk activation -For analysis of intracellular proteins from experimentally-treated or control AGS cells, equivalent amounts of each lysate were supplemented with Laemmli buffer for SDS-PAGE analysis. For Erk activation, antibodies directed against the phsophorylated active forms of Erk1/2 were employed (1:400). Membranes were subsequently stripped and reblotted for total Erk 1/2 (1:800), and Erk activation reported as phosphorylated Erk/total Erk. Mek and Raf activation levels were similarly determined, using antibodies for the phosphorylated and total populations of Mek and Raf. For CagA determinations, lysates were analyzed using anti-CagA antiserum (1:2000) . For MMP-1 determinations, supernatants were concentrated in Centricon™ centrifugal filter devices (M.W. cutoff 30,000) for 35 min at 5,000 x g at 4°C. Volume equivalents were assayed for MMP-1 by SDS-PAGE and immunoblotting with anti-MMP-1 antiserum (1:400). In each case, immunoblots were resolved by incubating with horseradish peroxidase-conjugated anti-rabbit antibody, imaged by chemiluminescence and autoradiography according to the manufacturer's instructions, and quantitated by densitometry (36) . Ras activation-Ras activity was determined as the binding to Ras of the Ras-binding Domain (RBD domain) of Raf, determined using an ELISA kit according to the manufacturer's instructions.
Plasmids -
The cagA open reading frames in H. pylori strains 147A, 147C and 7bqs were generated by PCR-amplifying the coding regions from DNA purified from the H. pylori cells using forward and reverse primers (EGFPSAC5 (5'-TAAGGAGAGCTCATGACTAACGAAAC TATTGAT) and SPKPN3m (5'TTCCTTGG TACCTTAAGATTTTTGGAAACCACCT) for 147A cagA and 147C cagA, and SPSAC5 (5'-TAAGGAGAGCTCATGACTAACGAAAC) and SPKPN3 (5'-TTCCTTGGTACCTTAA GATTTTTGGAAAC) for 7bqs-cagA), as previously reported (47, 51) . The resultant amplicons were inserted in-frame into SacI and KpnI sites in the multiple cloning region of the pSP65SRa mammalian expression vector. All constructs were verified by sequencing. 147A, 147C and 7bqs have zero, one and two type C EPIYA tyrosine phosphorylation motifs, respectively (47) .
RESULTS

H. pylori stimulates MMP-1 secretion from AGS cells via cagI-dependent and independent
processes --Co-culture of AGS cells overnight with strain Tx30a, lacking the cagI, stimulated MMP-1 secretion ( Figure 1A ,B). Co-culture with strain 147C (c a g A+) resulted in significantly increased MMP-1 secretion relative to Tx30a, whereas strain 147A (cagA+, but lacking the EPIYA tyrosine phosphorylation site) induced intermediate levels of MMP-1 secretion. Whereas immunoblotting of AGS cell lysates confirmed that cells co-cultured with strain Tx30a contained no CagA protein, AGS cells co-cultured with strains 147A and 147C had CagA introduced; 147C CagA was slightly greater in molecular weight than 147A CagA, consistent with the presence of an additional indel encoding the EPIYA motif (47) . CagA expression was consistently higher in cells cocultured with strain 147C ( Figure 1A ,B). The kinetics of MMP-1 secretion varied between strains ( Figure 1C ). MMP-1 secretion was observed earliest for cells co-cultured with strain 147C, followed by 147A, then Tx30a. These data indicate that H. pylori can stimulate MMP-1 secretion in the absence of the cagI, but that its presence increases MMP-1 secretion. Moreover, the presence of a tyrosine phoshorylation site on the CagA protein is associated with increased, and more rapid, MMP-1 secretion. Figure 2A ). The degree of Erk activation induced after 15 min did not differ significantly between the cagA+ and cagA-strains (Tx30a vs 147A, p=0.8; Tx30a vs 147C, p=0.2; 147A vs 147C, p=0.3). The cagA+ strains additionally induced a delayed (1-2 h) peak of Erk activation that was not observed with strain Tx30a (Figure  2A ,B). This second peak was more prominent, and of longer duration, in cells co-cultured with strain 147C, suggesting that the CagA EPIYA tyrosine phosphorylation site is required for optimal delayed Erk activation. Co-culture of the AGS cells with H. pylori did not affect total Erk levels (not shown). CagA protein was not observed in AGS cells after 15 min of H. pylori 147A or 147C co-culture, but was present as early as 30 minutes after co-incubation with either of the strains ( Figure 2B) . Thus, the kinetics of CagA expression in AGS cells was consistent with a role for CagA in late, but not early phase Erk activation. Despite continuing, and indeed increasing presence of 147A or 147C protein in AGS cells exposed to these H. pylori strains, Erk activation was transient, indicating that regulatory pathways may limit Erk activation in response to CagA. These data indicate that Erk activation by H. pylori is biphasic, with an early phase of CagAindependent Erk activation followed later by a larger, activation of Erk only in CagA+ strains.
H. pylori stimulates Erk activation via cagdependent and independent processes -
To determine the pathway(s) through which H. pylori acts to activate Erk, we tested the effect of H. pylori infection on Ras, Raf and Mek. These proteins constitute the canonical signaling cascade, activated by engagement of epidermal growth factor (EGF) receptors and other protein tyrosine kinase receptors (PTKR), leading to Erk activation. EGF stimulated Ras, Raf and Mek activation after 15 min, with a lesser degree of activation of each after 2 h (data not shown). Incubation of AGS cells with either Tx30a, 147A or 147C H. pylori cells for 15 min had no effect on Ras activation (Fig 3A) , whereas all three strains induced equivalent levels of both Raf and Mek activation after 15 min (Fig 3 B,C) .
Thus, rapid, Cag Aindependent Erk activation by H. pylori appears to involve Raf and Mek, but not Ras activation. After 2 h of co-incubation, strain Tx30a did not induce the activation of Ras, Raf or Mek (Fig  3D-E) . In contrast, 2 h of incubation with strain 147A or 147C resulted in stimulation of Ras, as well as Raf and Mek, with 147C providing the more potent stimulus. Thus, early CagAindependent Erk activation, and later CagAdependent Erk activation in response to H . pylori, proceed according to partially divergent signaling pathways. H. pylori-induced MMP-1 secretion is Erkdependent -To determine whether H. pyloriinduced MMP-1 secretion was Erk-dependent, we used UO126 (54), a specific inhibitor of Mek, the proximal activator of Erk (55) . UO126 inhibited early (15 min) Erk activation in response to co-culture with Tx30a, 147A, or 147C ( Figure 4A ), as well as later-phase (2h) Erk activation in response to 147A or 147C ( Figure 4B ). UO126 also inhibited MMP-1 secretion in response to co-culture with each of the three strains ( Figure 4C ). PD98059, another specific Mek inhibitor (56), also inhibited both Erk activation and MMP-1 secretion (data not shown). These results confirmed that MMP-1 secretion in response to co-culture with each of the three strains was Mek-and Erk-dependent.
Since p38 activity mediates MMP-1 secretion in dermal fibroblasts and several other cell types (57) (58) (59) , but inhibits MMP-1 secretion in cytokine-stimulated AGS cells (23), we also tested the effects of p38 inhibition on MMP-1 secretion from AGS cells. AGS cell incubation with the specific p38 inhibitor SB203580 (10 µM) (60) enhanced both early and late-phase Erk activation ( Figure 4A,B) , as well as MMP-1 secretion ( Figure 4C Figure 5B,C,E) . Transfection with 147A cagA induced less Erk activation than 147C cagA, confirming that type C EPIYA tyrosine phosphorylation plays a role in maximal direct Erk activation by CagA. Erk activation was transient, peaking at 3-8 h for both 147A and 147C, and returning to baseline by 24 h after transfection (data not shown).
Since co-culture of AGS cells with H. pylori stimulated both Erk activation and MMP-1 secretion, we next asked whether c a g A transfection also stimulates MMP-1 secretion.
CagA transfection resulted in increased MMP-1, with 147C cagA inducing greater MMP-1 secretion than 147A cagA ( Figure 5D,E) . Thus, the presence of CagA in the host cell is sufficient to stimulate MMP-1 secretion as well as Erk activation, and MMP-1 secretion is enhanced by the presence of the type C EPIYA tyrosine phosphorylation motif. In contrast to strain 147C, strain 7bqs contains an additional type C EPIYA region, making it susceptible to two phosphorylation events (47) 
Finally, we tested whether MMP-1 secretion in response to cagA tranfection is regulated by MAP kinases. Treatment of AGS cells with Mek inhibitors UO126 ( Figure 6A ,B) or PD98059 (data not shown) inhibited MMP-1 secretion in response to c a g A transfection, whether with 147A or 147C.
UO126 also inhibited MMP-1 secretion in response to transfection with 7bqs cagA (65±15% inhibition vs. 7bqs alone, p=0.006). Finally, we tested whether, in this system, p38 has a regulatory role in MMP-1 secretion. Consistent with our observations in AGS cells incubated with H . pylori, the p38 inhibitor SB203580 enhanced MMP-1 stimulation in response to transfection with cagA 147A or 147C ( Figure 6A,B) , as well as 7bqs (224±72% increase over 7bqs transfection alone, p=0.008). These findings indicate that the presence of CagA within a gastric epithelial cell is sufficient to induce Erk activation and MMP-1 secretion, whereas p38 does not mediate MMP-1 secretion, and may inhibit both CagA-induced Erk activity and MMP-1.
DISCUSSION
H. pylori gastric colonization stimulates inflammatory, erosive, and neoplastic processes (62) . That H. pylori strains lacking cagA induce less inflammation (63) , and are less commonly associated with both peptic ulceration, (19, 64) and gastric adenocarcinoma (18, 64) , suggests that inflammation and these processes may be linked. Although the mechanisms by which H. p y l o r i induces ulceration are not well understood, the ability of H. pylori to stimulate gastric cell secretion of various MMPs (24) (25) (26) (65) (66) (67) (68) suggests that H. pylori induces stromal destruction and host cell de-adherence via MMP-mediated degradation of collagens and other connective tissue proteins. These processes may also be important in invasive neoplasia (69) . The strong association of cagA with both ulcerogenesis and adenocarcinoma led us to hypothesize that the cagA product may drive host cell MMP secretion.
We observed that co-culture with H . pylori stimulated AGS cell secretion of MMP-1, an important MMP identified within ulcer lesions (28, 70) . Since type I and III collagens predominate in gastric mucosa (29, 44) , and both are susceptible to MMP-1, (45), these data suggest a mechanism for H. pylori-induced gastric stromal destruction. Blood vessels in the gastric lining contain types I and III collagen, as well as type II (also MMP-1-sensitive) (71)}; MMP-1 secretion may therefore also participate in gastric hemorrhage observed in H. pyloriinduced ulcers. The ability of microbes to regulate host cell metalloproteinase secretion to promote tissue breakdown is not limited to H. pylori.
Borrelia burdorferi, the pathogen causing Lyme disease, stimulates MMP-1 and 3 secretion from chondrocytes, and MMP-2 secretion from dermal fibroblasts and neurons, consistent with a role for MMP secretion in endorgan damage (72-74).
Our data indicate that H. pylori stimulates MMP-1 secretion by both cagIindependent and dependent processes. That strain Tx30a, which lacks the cagI, nevertheless induced MMP-1 secretion, confirms that H . p y l o r i co-culture is sufficient for cagIindependent MMP-1 induction. The cagI participates to maximize MMP-1 secretion, however, since extracellular MMP-1 concentrations increased significantly when AGS cells were co-cultured with cagI+ strains 147A or 147C. . Once inside the host cell, most CagA proteins, including that from 147C, are susceptible to c-Src/Lyn kinase-mediated phosphorylation of a tyrosine residue within a Ctype EPIYA motif (10, 13) . Co-culture of AGS cells with H. pylori strain 147C induced MMP-1 secretion greater than that of 147A (expressing CagA lacking the C-type EPIYA motif, but otherwise identical to that of 147C (47)), implicating intracellular CagA phosphorylation in maximal MMP-1 secretion.
Although H. pylori-stimulated gastric epithelial cell Erk activation has been reported, studies have differed regarding its CagAdependence (37) (38) (39) (40) . Our data indicate both CagA-independent and dependent processes. The early, transient Erk activation following coculture with either cagA+ or c a g A-strains is CagA-independent; its rapidity probably indicates outside-in signaling via bacterial/host receptor interactions. Pseudomonas aeruginosa rapidly and transiently activates Erk in human cells via contact-dependent ligation of host cell asialoGM1 receptors and intracellular calcium transients (75) ; whether a similar mechanism applies to H. pylori remains to be determined. A second, delayed Erk activation peak was induced only by cagA+ H. pylori strains, and greatly increased in the presence of the CagA tyrosine phosphorylation site (147C>147A), indicating that contact with the cagI-encoded structures is necessary, and that CagA phosphorylation is required for the maximal effect.
Our data also delineate differences in the signaling pathways through which H. pylori strains induce the early and delayed phases of Erk activation. The canonical pathway for Erk activation, elaborated in response to EGFR and other PTKRs, involves PTKR recruitment of Grb/SOS to the plasma membrane, leading to Ras, Raf, Mek and finally Erk activation. H. pylori-induced Erk activation after 2 h of incubation with CagA-positive strains appears to replicate this process, since 2 h incubation with 147A and 147C strains resulted in activation of all three upstream signaling elements (Ras, Raf, Mek). These observations are consistent with a previous suggestion that H. pylori may stimulate Erk activation via transactivation of the EGFR (76) . Consistent with the inability of strain Tx30a to stimulate late-phase Erk activation, Tx30a had no effect on Ras, Raf or Mek activation at the 2 h time point. In contrast, 15 min exposure of AGS cells to Tx30a, as well as 147A and 147C, each resulted in activation of Raf and Mek, consistent with CagA-independent activation of these molecules. Neither Tx30a, 147A nor 147C induced Ras activation at the 15 min time point however, indicating that early activation of the Erk signaling pathway depends upon a mechanism that bypasses Ras activation.
To determine whether the additional Erk activation and MMP-1 secretion observed in response to strains 147A and C were due strictly to CagA, or required other cagI-encoded structures, cagA transfection was studied. Transfection with either 147A or 147C c a g A resulted in MMP-1 secretion, indicating that intracellular CagA alone is sufficient to stimulate MMP-1 secretion. Consistent with the co-culture studies, the greater effect of 147C transfection in stimulating MMP-1 secretion indicated a regulatory role for CagA phosphorylation. Since the presence of an additional C-type EPIYA phosphorylation site in strain 7bqsCagA did not further induce MMP-1 secretion relative to 147C, Cag A phosphorylation likely regulates specific interaction(s) between CagA and targets, rather than non-specific net charge effects. In contrast, morphologic alterations in AGS cells induced by CagA appear proportional to the number of C-type EPIYA sites present (47, 77) Because 7bqs cagA has other differences from 147A and 147C (47) , the effect on MMP-1 secretion of multiple CagA phosphorylation sites requires further examination. Our data appear to differ from those of a recent report in which the authors concluded that MMP-1 secretion induced by H. pylori is CagA-independent (78). However, close review of the data presented in that report suggests that, in fact, a cagA-deficient H. pylori strain induced less MMP-1 secretion relative to a cagA+ strain, consistent with our current observations. Transfection with cagA constructs is a non-physiologic system for studying Erk activation, since in this system CagA accumulates gradually, whereas receptormediated Erk activation is a rapid, typically transient process. Physiologic CagA injection by H. pylori also is likely to cause more rapid CagA accumulation (79) , and therefore stimulate Erk more rapidly, than transfection. Nevertheless, cagA transfection induced transient Erk activation (147C>147A), paralleling MMP-1 secretion, and increasing confidence in the validity of this system. Both AGS cell Erk activation and MMP-1 secretion, in response to either H. pylori co-culture or cagA transfection, were inhibited by Mek inhibitors, confirming that MMP-1 secretion in these cells is mediated via Mek/Erk signaling (23) . Since Mek inhibitors reduced MMP-1 secretion in response to co-culture with either cag-negative strain Tx30, or cag positive strains 147A or 147C, Erk regulates both CagAindependent and dependent MMP-1 secretion. Since 1) phosphorylated CagA activates host cell SHP-2 (11), and 2) SHP-2 expression knockdown by siRNA abolishes Erk activation in AGS cells stably expressing an EPIYApositive CagA (80), both CagA-induced Erk activation and MMP-1 secretion likely are SHP-2-mediated. That Mek inhibition also regulates Erk activity and MMP-1 expression in rheumatoid synovial fibroblasts (36) and osteoarthritis chondrocytes (81) indicates that Erk pathway regulation of MMP-1 secretion is a conserved signaling pathway in cells involved with inflammation and erosion. Mek inhibition also reduces Erk activation, MMP-1 secretion, and collagenolysis, in invasive melanoma cells embedded in Type I collagen matrices (53) . The mechanisms by which Erk regulates gastric cell MMP-1 secretion have not been determined, but Erk signaling in other cells regulates MMP-1 secretion via AP-1 and ETS transcriptional activation (82) .
Both Erk activation and MMP-1 secretion were enhanced in response to p38 inhibitors, suggesting that p38 tonically suppresses H. pylori-stimulated MMP-1 secretion by inhibiting Erk. Even absent other stimulation, p38 inhibition induces AGS cell Erk activation and MMP-1 secretion, effects that are abrogated by Mek/Erk inhibitors (23) . These data differ from reports that p38 mediates MMP-1 secretion in dermal fibroblasts (57) (58) (59) , but are consistent with the effects of p38 inhibitors on MMP-1 secretion from cytokine-stimulated AGS cells (23) , as well as pancreatic cancer cells (83) ; p38 regulation of Erk and MMP-1 secretion is therefore cell type-specific. The observed ability of p38 inhibitors to enhance Erk activation and MMP-1 secretion must be interpreted with caution, since some investigators have suggested that SB203580 at 10 µM, but not ≤ 1 µM, may non-specifically activate c-Raf, leading to Erk activation (61, 84) . However, we observed SB203580 enhancement of Erk and MMP-1 at concentrations as low as 1.0 µM, suggesting an effect specific to p38, and consistent with a report that SB203580 activates Erk by inhibiting p38 specifically (85) . Interestingly, lower concentrations of SB203580 inhibited MMP-1 but not Erk, suggesting that p38 may regulate MMP-1 by both Erkdependent and independent effects. Since p38 facilitates gastric and oral mucosal healing (86, 87) , enhancement of gastric epithelial cell MMP-1 secretion by p38 inhibitors suggests that these agents, currently under investigation for rheumatoid arthritis (88), may prove ulcerogenic. However, p38 inhibitors also suppress cytokine-stimulated AGS cell secretion of MMP-13 (23, 89) , indicating that the overall effects of p38 on gastric stroma will depend upon multiple regulatory effects.
In conclusion, our studies confirm that H. pylori cells stimulate gastric epithelial MMP-1 secretion, but vary in their ability to do so according to their particular c a g A status; variations in H. pylori populations within an individual host will determine the net effect on MMP-1 secretion (Figure 7 ). Both CagAdependent and independent MMP-1 secretion are regulated by Erk (via divergent signaling pathways), and probably inhibited by p38. The ability of H. pylori to activate gastric MMP-1 secretion via Erk activation provides a mechanism relevant to ulcerogenesis, and possibly neoplasia, and suggests strategies through which H. pylori-induced gastric damage might be ameliorated. 4 These authors contributed equally to this work.
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